Andrea Pisesky | Congenital Heart Defects | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Andrea Pisesky
Stollery Children’s Hospital

Andrea Pisesky
Affiliation Stollery Children’s Hospital
Country Canada
Scopus ID 57219721692
Documents 9
Citations 478
h-index 7
Subject Area Congenital Heart Defects
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0003-0094-0193

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada, with a documented research profile associated with congenital heart defects and cardiovascular medicine. The supplied bibliometric information records nine documents, 478 citations, and an h-index of 7. The profile also includes ORCID identifier 0000-0003-0094-0193, supporting persistent researcher identification. [1] [2]

Abstract

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada whose documented scholarly profile focuses on congenital heart defects and cardiovascular medicine. The supplied bibliometric record identifies nine documents, 478 citations, and an h-index of 7 under Scopus author identifier 57219721692. These indicators provide a quantitative representation of documented research activity and citation visibility. The profile is additionally associated with ORCID identifier 0000-0003-0094-0193, supporting researcher identification and record disambiguation. This article presents the available academic information in a structured recognition profile, covering research orientation, contributions, publications, citation impact, and relevance to consideration for a Best Researcher Award within cardiovascular medicine.

Keywords

Andrea Pisesky, Best Researcher Award, congenital heart defects, cardiology, cardiovascular medicine, Stollery Children’s Hospital, Canada, Scopus, ORCID, research impact. [1] [2]

Introduction

Congenital heart defects are an important area of cardiovascular research because structural abnormalities of the heart and major vessels can require continuing clinical assessment and multidisciplinary management. Research in this field encompasses diagnosis, intervention, outcomes, epidemiology, and long-term care. Bibliographic databases such as Scopus provide standardized indicators that can assist in describing documented scholarly activity and citation performance. [1] [5]

Research Profile

The supplied profile places Andrea Pisesky within the research area of congenital heart defects and cardiovascular medicine, with an institutional affiliation at Stollery Children’s Hospital in Canada. The reported Scopus record contains nine documents, 478 citations, and an h-index of 7. ORCID identifier 0000-0003-0094-0193 provides an additional persistent identifier for researcher disambiguation. [1] [2]

Research Contributions

The documented subject focus is relevant to congenital cardiac conditions and cardiovascular medicine, disciplines that rely on clinical investigation, patient characterization, treatment evaluation, outcomes research, and interdisciplinary collaboration. Based on the supplied information, the research profile can be described within this broad domain without attributing specific scientific findings that are not independently established by the available publication record. [3]

Publications

The supplied Scopus information records nine documents associated with author identifier 57219721692. These documents constitute the reported scholarly output underlying the stated citation count and h-index. Publication-level details such as article titles, journals, dates, authorship, and DOI identifiers should be verified against the relevant bibliographic records before being used for detailed assessment. [1]

Research Impact

The reported bibliometric profile contains 478 citations and an h-index of 7. These measures provide quantitative indicators of citation activity associated with the supplied author record. Citation counts are dynamic and may change as databases are updated; consequently, bibliometric indicators should be considered alongside publication quality, research relevance, methodological contribution, and broader academic or clinical influence. [1]

Award Suitability

The available academic indicators provide relevant evidence for consideration within a researcher recognition framework focused on cardiology and cardiovascular medicine. The combination of documented scholarly output, citation activity, subject-area relevance, institutional affiliation, and persistent researcher identification can support an evidence-based nomination. Final eligibility and recognition should be determined according to the official criteria and review procedures of the organizing body. [4]

Conclusion

Andrea Pisesky’s supplied academic profile reflects research activity associated with congenital heart defects and cardiovascular medicine in Canada. The reported Scopus indicators of nine documents, 478 citations, and an h-index of 7 provide measurable evidence of documented scholarly visibility. Together with ORCID identification and institutional affiliation, these indicators form a structured basis for an academic recognition profile while remaining subject to independent verification and formal award evaluation.

References

  1. Elsevier. (n.d.). Scopus author details: Andrea Pisesky, Author ID 57219721692. Scopus.
    https://www.scopus.com/pages/authors/57219721692
  2. ORCID. (n.d.). ORCID record: Andrea Pisesky. ORCID.
    https://orcid.org/0000-0003-0094-0193
  3. Journal article(2021.). Adverse fibrosis remodeling and aortopulmonary collateral flow are associated with poor Fontan outcomes.
    https://doi.org/10.1186/s12968-021-00782-9
  4. Journal article(2021.). Cardiology and Cardiovascular Medicine. Standardisation of management after Norwood operation has not improved 1-year outcomes.
    https://doi.org/10.1017/S1047951120003376
  5. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Emilia D’Elia | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Emilia D’Elia
ASST Papa Giovanni XXIII, Italy

Emilia D’Elia
Affiliation ASST Papa Giovanni XXIII
Country Italy
Scopus ID 40660899000
Documents 100
Citations 1,647
h-index 19
Subject Area Heart Failure
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-6682-0074

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a research profile focused on heart failure. The supplied bibliometric record reports 100 documents, 1,647 citations, and an h-index of 19, providing measurable indicators of scholarly productivity and visibility within cardiovascular medicine.[1]

Abstract

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a documented research profile in heart failure. Available bibliometric information identifies 100 documents, 1,647 citations, and an h-index of 19, indicating sustained publication activity and measurable academic visibility. Her subject specialization places her work within contemporary cardiovascular medicine, where heart failure research addresses diagnosis, treatment, outcomes, and disease management. The profile provides a quantitative basis for considering research recognition while acknowledging that bibliometric indicators should be interpreted alongside publication quality, originality, clinical relevance, collaboration, and broader contributions to cardiovascular science and patient care.[1]

Keywords

Emilia D’Elia; heart failure; cardiology; cardiovascular medicine; clinical research; scholarly impact; bibliometrics; citations; h-index; cardiovascular outcomes; ASST Papa Giovanni XXIII; Italy; research recognition; Best Researcher Award.

Introduction

Heart failure is a major area of cardiovascular research requiring evidence across prevention, diagnosis, pharmacological management, device therapy, and long-term outcomes. Contemporary clinical guidance emphasizes multidisciplinary and evidence-based approaches to improving outcomes for affected patients.[2] Researchers specializing in heart failure contribute to the development and evaluation of clinically relevant evidence.

Research Profile

The supplied profile identifies Emilia D’Elia with ASST Papa Giovanni XXIII in Italy and associates her principal subject area with heart failure. Her Scopus author identifier is 40660899000, while the reported record comprises 100 documents, 1,647 citations, and an h-index of 19. These indicators describe a research profile with established bibliometric visibility.[1]

Research Contributions

The available information supports characterization of D’Elia’s research within heart failure and cardiovascular medicine. Research in this field can contribute to understanding disease mechanisms, improving risk assessment, evaluating therapeutic strategies, and strengthening evidence-based clinical care. The documented publication and citation record provides measurable evidence of sustained engagement with the scientific literature.[1]

Publications

The supplied Scopus information reports 100 documents associated with the researcher profile. Because individual publication titles, journals, publication years, and article-level identifiers were not provided, this article does not assign specific publications or DOIs without verification. The complete bibliographic record can be reviewed through the linked Scopus author profile.[1]

Research Impact

The reported 1,647 citations and h-index of 19 provide quantitative measures of scholarly influence within the indexed research record. Citation metrics can assist in evaluating research visibility, although they do not independently establish methodological quality, originality, clinical effectiveness, or societal benefit. A balanced assessment should therefore consider both bibliometric and qualitative evidence.[1]

Award Suitability

Based on the supplied information, Emilia D’Elia presents characteristics relevant to consideration for a Best Researcher Award in cardiology and cardiovascular medicine, particularly through her documented activity in heart failure research and established bibliometric record. Final award assessment should additionally consider originality, publication quality, research leadership, clinical relevance, collaboration, and independently verifiable achievements.

Conclusion

Emilia D’Elia’s supplied academic profile reflects sustained research activity in heart failure and cardiovascular medicine, supported by 100 reported documents, 1,647 citations, and an h-index of 19. These indicators provide a quantitative foundation for academic recognition, while a complete award evaluation should incorporate verified publication quality, scientific originality, clinical significance, and broader research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Emilia D’Elia, Author ID 40660899000. Scopus.
    https://www.scopus.com/pages/authors/40660899000
  2. Journal article (2025.). SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.
    https://doi.org/10.1093/eurheartjsupp/suae117
  3. Journal article. (2026.). Sex-related disparities in elderly patients with heart failure with mildly reduced or preserved ejection fraction.
    https://doi.org/10.1093/eschf/xvaf022
  4. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Published on by Cardiology and Cardiovascular Medicine

Assoc. Prof. Dr. Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Istanbul University-Cerrahpasa Cardiology Institute | Turkey

Umit Yaşar Sinan is an accomplished cardiovascular specialist whose career reflects sustained academic excellence, broad clinical expertise, and meaningful contributions to contemporary cardiology. After completing rigorous medical and cardiology training at leading institutions, he advanced rapidly through academic ranks and currently serves as an Associate Professor of Cardiology, where he is recognized for his dedication to research, teaching, and advanced patient care. His international experience includes focused work in adult congenital heart disease and pulmonary hypertension at a major UK referral center, strengthening his profile in complex cardiac conditions. Over the years, he has cultivated deep clinical interests spanning echocardiography, invasive cardiology, structural heart disease, pulmonary hypertension, adult congenital heart disease, heart failure, and atherosclerosis. His scholarly productivity is reflected in 90 scientific documents, which have collectively received 559 citations from 531 sources, supporting an h-index of 14 an indicator of his growing influence in cardiovascular research. He remains actively engaged in professional communities, holding memberships and leadership roles across prominent international and national cardiology societies, where he contributes to collaborative initiatives in acute cardiovascular care, imaging, valvular heart disease, congenital heart disease, and pulmonary vascular disorders. Through this blend of academic leadership, clinical depth, and research impact, he continues to shape advancements in cardiology both within his institution and across the broader scientific community.

Profile: Scopus | Orcid

Featured Publications

Yaylalı, Y. T., Yağmur, B., Sinan, Ü. Y., Meriç, M., Başarıcı, İ., Kılıçkıran Avcı, B., Şenol, H., Nalbantgil, S., Küçükoğlu, S., & Öngen, Z. (2023). Risk assessment tool implementation in congenital heart disease-associated pulmonary arterial hypertension. Anatolian Journal of Cardiology, 27(8), 479-485.

Kocabaş, U., Ergin, İ., Kıvrak, T., Yılmaz Öztekin, G. M., Tanık, V. O., Özdemir, İ., Avcı Demir, F., Doğduş, M., Şen, T., Altınsoy, M., Üstündağ, S., Urgun, Ö. D., Sinan, Ü. Y., Uygur, B., Yeni, M., & Özçalık, E. (2023). Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction. ESC Heart Failure, 10(6), 3677-3689.

Akyıldız Akçay, F., Sinan, Ü. Y., Gürbüz, D. Ç., Şafak, Ö., Kaya, H., Yüksek, Ü., & Zoghi, M. (2023). Gender-related differences in patients with acute heart failure: Observation from the Journey Heart Failure-Turkish Population Study. Anatolian Journal of Cardiology, 27(11), 639-649.

Sinan, U. Y., Serin, E., Keskin-Meriç, B., & Arat-Ozkan, A. (2023). Cre8 drug eluting stent performance in daily cardiology practice. IMR Press, 24(2), 53.

Şabanoğlu, C., Sinan, Ü. Y., Akboğa, M. K., Çoner, A., Gök, G., Kocabaş, U., Bekar, L., Gazi, E., Cengiz, M., Kılıç, S., İnanç, İ. H., Çakmak, H. A., & Zoghi, M. (2023). Long-term prognosis of patients with heart failure: Follow-up results of Journey HF-TR study population. Anatolian Journal of Cardiology, 27(1), 26-33.

Getu Gizaw | Cardiovascular Researches | Editorial Board Member

Published on by Cardiology and Cardiovascular Medicine

Dr. Getu Gizaw | Cardiovascular Researches | Editorial Board Member

Jimma University | Ethiopia

Getu Gizaw is an Assistant Professor of Human Nutrition at Jimma University, Ethiopia, and a seasoned academic and researcher with extensive experience in maternal and child health, acute malnutrition management, and public health nutrition across humanitarian and development settings. With more than nine years of involvement in observational studies and randomized controlled trials, he has contributed significantly to evidence generation on the impacts of malnutrition and the effectiveness of simplified, community-based treatment approaches. He has played major roles in high-impact research, including a large UNICEF-supported randomized controlled trial evaluating cost-effective strategies for treating acute malnutrition, where he contributed to protocol development, data management, field coordination, staff supervision, training, and donor reporting. At Jimma University, he lectures on nutritional epidemiology, diet and disease, and emergency nutrition, supervises postgraduate students, and participates in institutional and national technical working groups focused on updating and adapting guidelines for wasting prevention and malnutrition management. Based in Addis Ababa, he also works as an independent consultant, specializing in study design, implementation research coordination, program monitoring and evaluation, and stakeholder engagement, supporting organizations in strengthening the quality and impact of public health and nutrition interventions. Skilled in advanced statistical analysis and widely published in peer-reviewed journals, he remains committed to advancing research-driven, context-appropriate solutions that improve maternal and child health outcomes and contribute to national and global nutrition agendas.

Profiles: Scopus | Orcid

Featured Publications:

Gizaw, G., Mekonnen, N., Mamo, A., Fekadie, A., Nigussie, S., G/Egziabher, M., Mekonin, W., Girma, S., Mulat, S., Mekonnen, A., et al. (2025). Effects of an egg production intervention with social behavioral change communication and subsidy on child dietary diversity in Ethiopia. Scientific Reports.

Ahmed, E., Gizaw, G., & Argaw, A. (2025). Association between self-reported sleep quality and body mass index among Jimma University academic staff: Structural equation modeling. BMC Nutrition.

Trehan, I., Beyene, Y., Darsene, H., Adams, B. S., Wrabel, M., Gizaw, G., Legese, L. A., Cichon, B., Chitekwe, S., Shellemew, M. W., et al. (2025). The Modified Dosages for Acute Malnutrition (MODAM) study: Protocol for three integrated randomized controlled trials of novel approaches for the management of childhood wasting in Ethiopia. BMC Nutrition.

Tamiru, D., Girma, S., & Gizaw, G. (2025). Contributing factors to acute malnutrition among children admitted to public health facilities in South West Ethiopia: A matched case–control study. Frontiers in Nutrition.

Gizaw, G., Wells, J. C., Argaw, A., Olsen, M. F., Abdissa, A., Asres, Y., Challa, F., Berhane, M., Abera, M., Sadler, K., et al. (2025). Associations of early childhood exposure to severe acute malnutrition and recovery with cardiometabolic risk markers in later childhood: 5-year prospective matched cohort study in Ethiopia. The American Journal of Clinical Nutrition.

Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Shenzhen University | China

Mr. Ibtasam Wajid is an emerging researcher whose work focuses on the intersection of biomedical engineering, health informatics, and data science, with a particular interest in developing innovative machine learning and deep learning models for improving healthcare outcomes. His research explores how advanced computational techniques can be applied to disease prediction, medical imaging, and clinical decision support, contributing to the growing field of digital health transformation. With an academic background spanning biochemistry, health informatics, and biomedical research, he brings an interdisciplinary perspective to addressing complex challenges in modern medicine. He has authored three research documents, accumulating a total of six citations and holding an h-index of one, reflecting a steadily growing research impact at an early stage of his academic career. Alongside his research contributions, he has actively participated in mentoring undergraduate students, organizing technical workshops, and promoting collaborative learning environments within the scientific community. His ongoing studies and projects continue to focus on integrating artificial intelligence into healthcare systems to enhance accuracy, efficiency, and patient-centered care. Through his dedication to continuous learning and innovation, he demonstrates the potential to make lasting contributions to biomedical science and the advancement of data-driven healthcare solutions worldwide.

Profiles: Scopus | Google Scholar

Featured Publications

Sultan, H., Javed, I., Zubair, M., Iqbal, K., Bilal, M., Iqbal, J., & Wajid, I. (2021). Protein and polysaccharide-based biomaterial for the formation of composite bone scaffold. AlQalam Journal of Medical and Applied Sciences, 4(2), 80–88.

Wajid, I., Dan, L., & Wang, Q. (2025). Hybrid ensemble approaches for cardiovascular disease prediction: Leveraging interpretable AI for clinical insight. Intelligence-Based Medicine, 100297.

Ishaq, S., Afzal, S., Usmani, S. A., Wajid, I., Aziz, A., Tahir, R., Ahmad, A., & Ullah, A. (2025). Inflammatory cell death and leukemia treatment. Critical Reviews in Oncology/Hematology, 104909.

Thilini Jayasinghe | Cardiovascular Researches | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Thilini Jayasinghe | Cardiovascular Researches | Best Research Article Award

The Univeristy of Sydney | Australia

Dr. Thilini Jayasinghe is a dedicated and forward-thinking early-career researcher specializing in the complex interplay between the oral and gut microbiomes, inflammation, and nutrition in chronic disease contexts. She has authored 25 documents, comprising peer-reviewed publications, book chapters, and research articles, which have collectively accumulated 474 citations, reflecting the significance and reach of her work within the scientific community. Her research achievements are further highlighted by an h-index of 11, demonstrating both productivity and impact. Over the past eight years, Dr. Jayasinghe has contributed to and led multidisciplinary studies spanning epidemiological, clinical, and pre-clinical models, collaborating with teams across eight countries, with more than half of her publications arising from international partnerships. She has successfully secured competitive research grants and played a pivotal role in ethics submissions, clinical trial protocols, and biobank initiatives. Her technical expertise encompasses molecular microbiology, bioinformatics, multi-omics integration, animal model research, and clinical trial design, alongside strong project leadership and mentorship skills. Currently serving as a Research Fellow at the University of Sydney, she leads translational research projects, supervises students at various academic levels, and contributes to teaching programs. Dr. Jayasinghe’s work continues to advance understanding of diet–microbiome–inflammation interactions, aiming to improve human health outcomes globally.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Wilson, B. C., Zuppi, M., Derraik, J. G. B., Albert, B. B., Tweedie-Cullen, R. Y., Leong, K. S. W., Beck, K. L., Vatanen, T., O’Sullivan, J. M., Cutfield, W. S., & on behalf of the Gut Bugs Study Group (including Jayasinghe, T.). (2025). Long-term health outcomes in adolescents with obesity treated with faecal microbiota transplantation: 4-year follow-up. Nature Communications, 16, 7786.

Jayasinghe, T., Jenkins, J., Medara, N., Choowong, P., Dharmarathne, G., Kong, F., Cho, H., Kim, S. H., Zhang, Y. G., Franco-Duarte, R., Eberhard, J., & Spahr, A. (2025). Dietary fibre modulates body composition, blood glucose, inflammation, microbiome, and metabolome in a murine model of periodontitis. Nutrients, 17(7), 1146.

Dharmarathne, G., Kazi, S., King, S., & Jayasinghe, T. N. (2024). The bidirectional relationship between cardiovascular medications and oral and gut microbiome health: A comprehensive review. Microorganisms, 12, 2246.

Jayasinghe, T. N., & Spahr, A. (2023). Dietary supplementation of omega-3 fatty acids could be used as an adjunct therapy to nonsurgical periodontal treatment. Journal of Evidence-Based Dental Practice, 101925.

Chopra, A., Jayasinghe, T. N., & Eberhard, J. (2022). Are inflamed periodontal tissues endogenous source of advanced glycation end-products (AGEs) in individuals with and without diabetes mellitus? A systematic review. Biomolecules, 12, 642.

 

Dani Qin | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Dani Qin | Cardiovascular Disease | Best Researcher Award

Yixing People's Hospital | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qin Dani began her academic journey with a strong foundation in pediatrics, completing her studies at a prestigious medical university and further pursuing advanced training. Her dedication to continuous learning is evident as she continues doctoral studies at a reputed university. Her academic background laid the groundwork for her clinical expertise and research orientation in pediatric healthcare.

Professional Endeavors

She has established herself as a key figure in the Department of Pediatrics at Yixing People's Hospital, where she has been contributing her expertise for many years. During her career, she also pursued advanced studies and training at well-regarded medical institutions, which broadened her clinical skills and enriched her professional development. She currently holds a leadership role as an Associate Chief Physician and plays an active part in pediatric development teams, shaping the direction of child healthcare services.

Contributions and Research Focus

Her clinical work spans the diagnosis and treatment of a wide spectrum of pediatric conditions, with particular strengths in infant and toddler health care, respiratory disorders, digestive system diseases, and neonatal health management. She has led several important research projects at provincial and municipal levels, demonstrating her commitment to bridging clinical practice with academic research. Her published works reflect a dedication to advancing pediatric medicine through evidence-based studies and practical insights.

Impact and Influence

Through her leadership and expertise, she has significantly contributed to improving pediatric care standards in her community and beyond. Her ability to manage both common and critical pediatric illnesses has earned her recognition among colleagues and institutions alike. Her influence extends to mentoring young professionals, thereby fostering the next generation of pediatric specialists.

Academic Cites

She has authored numerous academic publications in both international and national journals, with multiple contributions recognized in core and indexed platforms. Her scholarly work has been acknowledged through prestigious awards in natural science and academic excellence, showcasing her impact in both scientific and clinical communities.

Legacy and Future Contribution

Her career trajectory reflects a deep commitment to pediatric medicine, both in clinical practice and academic advancement. With her ongoing doctoral research, she is expected to make further strides in pediatric healthcare innovations. Her legacy will likely continue through her contributions to research, her role in nurturing young professionals, and her influence on public health standards in pediatrics.

Recognition and Honors

She has received several commendations from healthcare authorities and academic institutions for her outstanding contributions, including recognition for advanced individual achievements and excellence in academic publications. These accolades highlight her dedication, professionalism, and long-term impact in the medical field.

Conclusion

Qin Dani exemplifies the qualities of an accomplished physician, researcher, and academic leader. Her blend of clinical expertise, research achievements, and commitment to advancing pediatric medicine has left a lasting mark on both medical practice and scientific scholarship. With a proven record of excellence and continued pursuit of innovation, she stands as a role model in the field of pediatrics, poised to make even greater contributions in the years ahead.

Notable Publications

"Methionine sulfoxide suppresses adipogenic differentiation by regulating the mitogen‐activated protein kinase signaling pathway"

Authors: Dani Qin; Yong Lei; Wen Xie; Qiuju Zheng; Zhou Peng; Yiwen Liu; Biao Dai; Tieliang Ma; Ping
Journal: Cell Biology
Year: 2023

"Effects of miR-19b Overexpression on Proliferation, Differentiation, Apoptosis and Wnt/β-Catenin Signaling Pathway in P19 Cell Model of Cardiac Differentiation In Vitro"

Authors: Da-Ni Qin; Lingmei Qian; De-Liang Hu; Zhang-Bin Yu; Shu-Ping Han; Chun Zhu; Xuejie Wang;
Journal: Cell Biochemistry and Biophysics
Year: 2013

Hua He | Coronary Artery Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Hua He | Coronary Artery Disease | Best Researcher Award

Beijing Anzhen Hospital Affiliated to Capital Medical University | China

Author Profile:

Scopus

Orcid

🩺 DR. HUA HE – A PIONEERING HEART SPECIALIST

👶 EARLY ACADEMIC PURSUITS

Professor Hua He began her medical journey with a strong academic foundation. In 2006, she earned her Doctor of Medicine (M.D.) in Internal Medicine from the prestigious Peking Union Medical College, one of China’s top medical institutions. During her formative academic years, she displayed exceptional interest in cardiovascular health, laying the groundwork for her future contributions to the field of cardiology.

💼 PROFESSIONAL ENDEAVORS

Currently serving as a Professor and Chief Physician at Beijing Anzhen Hospital, Capital Medical University, Professor Hua He has dedicated her career to advancing clinical practices in cardiovascular medicine. Her professional role combines teaching, clinical care, and research, making her a multi-faceted leader in internal medicine and cardiology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CORONARY ARTERY DISEASE

Professor He’s research has consistently targeted some of the most critical conditions in cardiovascular health. Her expertise spans:

  • Coronary Heart Disease

  • Arrhythmia

  • Heart Failure

More recently, her pioneering investigations into mesenchymal stem cells and their derivatives have opened promising new avenues for the treatment of ischemic heart disease. As principal investigator, she has led numerous funded research projects and experimental studies in regenerative cardiology.

📚 ACADEMIC CITES AND PUBLICATIONS

Professor Hua He has authored over 10 peer-reviewed publications, each contributing valuable insights to the cardiology research community. Her work is frequently cited by researchers and clinicians exploring new frontiers in stem cell therapy, cardiac repair, and disease modulation. These citations reflect the credibility and scientific impact of her scholarly work.

🌍 IMPACT AND INFLUENCE

Her work has had a meaningful influence not only in clinical settings, where her therapies are contributing to patient recovery and rehabilitation, but also in academic spheres, where her findings continue to shape medical discourse on cardiovascular regeneration. As a mentor and educator, she plays a vital role in nurturing the next generation of physicians and researchers.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

With a career built on innovation and compassion, Professor Hua He is establishing a legacy as one of China’s most forward-thinking medical researchers in cardiovascular treatment. Looking ahead, she is expected to:

  • Expand her research on stem-cell-derived therapies

  • Enhance collaborative international studies

  • Influence cardiac treatment protocols worldwide

Her enduring commitment to research, education, and clinical practice ensures that her contributions will resonate for generations.

📑NOTABLE PUBLICATIONS

"Association between the (neutrophil + monocyte)/albumin ratio and all-cause mortality in sepsis patients: a retrospective cohort study and predictive model establishment according to machine learning"

Authors: T., Lulu Liu; Qian Ma; Guangzan Yu; Xuhou Ji; Hua He
Journal: BMC Infectious Diseases
Year: 2025

"Association between cardiorenal syndrome and depressive symptoms among the US population: a mediation analysis via lipid indices"

Authors: Guangzan Yu; Lulu Liu; Qian Ma; Hua He
Journal: Lipids in Health and Disease
Year: 2024

"Non-linear Association of CAR with all-Cause and Cardiovascular Mortality in Coronary Heart Disease: A Retrospective Cohort Study from NHANES"

Authors: Ming Ye; Guangzan Yu; Fusheng Han; Hua He
Journal: Clinical and Applied Thrombosis/Hemostasis
Year: 2024

Yusheng Liu | Interventional Cardiology | Best Researcher Award 

Published on by Cardiology and Cardiovascular Medicine

Prof. Yusheng Liu | Interventional Cardiology | Best Researcher Award

The Second Hospital of Shandong University | China

Author Profile:

Scopus

🩺 PROF. YUSHENG LIU – A PIONEER IN HEART FAILURE & ECHOCARDIOGRAPHY

🎓 EARLY ACADEMIC PURSUITS

Prof. Yusheng Liu began his illustrious academic journey in Clinical Medicine at Taishan Medical School (now The First Medical University of Shandong), earning his Bachelor’s degree (1995–2000). His quest for deeper knowledge led him to pursue a Master’s degree in Internal Medicine with a focus on Cardiovascular Disease at Shandong University School of Medicine (2004–2007), followed by an M.D. in Cardiovascular Medicine (2010–2013) from the same institution.

👨‍⚕️ PROFESSIONAL ENDEAVORS

Since July 2000, Prof. Liu has served at the Second Hospital of Shandong University, currently holding the title of Deputy Chief Physician of Cardiovascular Medicine, Associate Professor, and Doctoral Supervisor. He also leads the Cardiac Care Unit (CCU) and plays a pivotal role in guiding the next generation of clinicians as a Master’s tutor.

His career also extends into professional societies, where he holds several leadership roles, including:

  • Executive Director, China Ultrasonic Medical Engineering Society (Echocardiography Division)

  • Vice Chairman, Shandong Ultrasound in Medicine Engineering Institute

  • Youth Leader, Shandong Medical Health System

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON INTERVENTIONAL CARDIOLOGY

Prof. Liu has dedicated his research to heart failure, echocardiography, coronary artery disease, and atherosclerosis. He has:

  • Led or contributed to multiple National Key Projects such as 973, 863, and the National Natural Science Foundation

  • Chaired international collaborations like the Macau SAR Science & Technology Fund

  • Focused heavily on biomarker-based diagnostics, ventricular function in diabetes, and plaque stability in coronary syndromes

His projects have bridged clinical and basic science, contributing to real-world patient improvements and high-impact academic knowledge.

🏆 IMPACT AND INFLUENCE

Prof. Liu’s work has been nationally and internationally recognized:

  • Two-time winner of National Science and Technology Progress Award

  • Recipient of multiple provincial awards including 4 second-place and 6 third-place Science & Tech Awards

  • Frequent keynote speaker at conferences such as:

    • 24th Great Wall International Cardiology Conference

    • 12th National Echo Cardiac Conference

    • 2016 Pharmacology & Ethnopharmacology Conference, Chicago, USA

He is also involved in clinical ethics, oncology cardiology, heart rehabilitation, and hypertension professional committees.

📚 ACADEMIC CITATIONS AND MEMBERSHIPS

Prof. Liu is a proud member of:

  • American Society of Echocardiography (ASE)

  • China Ultrasound Medical Engineering Society (Permanent Member)

  • Various Shandong Medical Associations across cardiology, ethics, and disaster medicine

His publications and research are cited in numerous national and international cardiovascular journals and conferences, further amplifying his impact on the global stage.

🧪 SCIENTIFIC PROJECTS (SELECTED)

Some of the noteworthy research projects under his leadership include:

  1. Huatong-Guokang Medical Scientific Research Project – Ministry of Education (2023)

  2. Clinical Elite Scientist Programme (2018)

  3. National Key R&D Plan (2022YFC3502100)

  4. Lipoprotein-Associated Phospholipase A2 and Plaque Stability (2014)

  5. JNK Pathway and Atherosclerosis Mechanism (2013)

  6. DPP-4 Inhibitors and Ventricular Function in Diabetic Patients (2013)

🏅 AWARDS AND HONORS

Prof. Liu has received:

  • Lecture Honorary Certificate – Pharmacology & Ethnopharmacology 2016

  • Shandong Soft Science Excellence Award

  • Outstanding Teaching Certificate – Weifang University (2016)

  • Advanced Medical Worker Honor – Phoenix Media

  • Scholarships from Shandong University and affiliated hospitals

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Prof. Yusheng Liu stands as a leading voice in the evolution of cardiovascular care in China and beyond. His multidisciplinary influence spans clinical excellence, scientific innovation, academic mentorship, and global collaboration.

In the years to come, his focus on integrating precision medicine, biomarkers, and advanced imaging will continue shaping the future of heart failure diagnostics, ultrasound cardiology, and clinical translational research. With a legacy rooted in innovation and education, he continues to inspire and uplift the cardiovascular medicine community.

📑 NOTABLE PUBLICATION

"Analysis of Platelet Morphological Parameters as Clinical Risk Stratification in Acute Coronary Syndrome"

Authors: Xuguang Zhang, Zhiwei Huang, Xin Wang, Han Hao, Dali Fan, Martin Cadeiras, Yusheng Liu
Journal: Catheterization and Cardiovascular Interventions
Year: 2025

 

Wei Eric Wang | Myocardial Infarction | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Wei Eric Wang | Myocardial Infarction | Best Researcher Award

Prof. Wei Eric Wang, Southwest Hospital, Army Medical University, China

Prof. Wei Eric Wang is a distinguished medical professional based at Southwest Hospital, Army Medical University, in China. Renowned for his expertise in medical research and clinical practice, he has contributed significantly to the fields of surgery, healthcare management, and medical education. With numerous publications in peer-reviewed journals, Prof. Wang has established a reputation for pioneering studies in his area of specialization. He is also actively involved in advancing medical training, and his leadership at the hospital continues to shape healthcare innovation in China. His work has earned him recognition both nationally and internationally.

AUTHOR PROFILE

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS:

Dr. Wei (Eric) Wang pursued his medical education at the Third Military Medical University in Chongqing, China. He earned his M.D. in Clinical Medicine from 2000 to 2005. Following this, he completed his Ph.D. at the Institute of Burn Surgery, Southwest Hospital, at the same university between 2005 and 2010. His early academic endeavors laid the foundation for his expertise in cardiology and geriatric medicine.

🏥PROFESSIONAL ENDEAVORS:

Dr. Wang has held various prestigious positions throughout his career. He has been the Director of the Department of Geriatrics at Southwest Hospital since November 2022, demonstrating his leadership in the field. Prior to this, he served as Chief Physician and Professor in the Department of Cardiology at Daping Hospital, Army Medical University. His extensive experience includes roles such as Deputy Director, Associate Chief Physician, Attending Doctor, and Resident, reflecting his progressive career growth and expertise in cardiology and geriatrics.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Myocardial Infarction

Dr. Wang’s research is centered on new strategies for treating cardiovascular diseases, particularly myocardial infarction and heart failure. His primary areas of focus include:

  1. Mechanisms regulating cardiac regeneration.
  2. Translational and clinical studies for treating cardiovascular diseases.
  3. Translational and clinical research for preventing aging.

His work has significantly advanced the understanding of cardiac repair mechanisms and potential therapeutic interventions.

🌍IMPACT AND INFLUENCE:

Dr. Wang has played a crucial role in the field of cardiology and geriatrics. His research has contributed to innovative treatments that enhance cardiac regeneration and improve patient outcomes. As a leader in cardiovascular medicine, his influence extends beyond clinical practice to shaping future medical research and treatment methodologies.

📚ACADEMIC CITATIONS AND RECOGNITION:

Dr. Wang has an impressive list of publications in esteemed medical journals. Some of his notable works include:

  1. “Metabolic reprogramming: a byproduct or a driver of cardiomyocyte proliferation?” published in Circulation (2024).
  2. “Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ-NONO heteromer-induced DNA repair,” published in Basic Research in Cardiology (2022).
  3. “The Role of G Protein-Coupled Receptor Kinase 4 in Cardiomyocyte Injury after Myocardial Infarction,” published in European Heart Journal (2021).
  4. “Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury,” published in Circulation (2017).

These publications highlight his extensive contributions to cardiovascular research and his role in advancing medical knowledge in this domain.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Wang’s legacy is deeply rooted in his contributions to cardiovascular research, innovative treatment strategies, and leadership in geriatric medicine. As a distinguished professor and researcher, his work continues to shape the future of cardiology and geriatrics. His ongoing research and clinical innovations are expected to provide new breakthroughs in cardiac care and aging prevention, benefiting future generations of patients and medical professionals.

🚀CONCLUSION:

Prof. Wei Eric Wang is a distinguished cardiologist and geriatrician whose groundbreaking research and leadership have significantly impacted cardiovascular medicine. His dedication to innovation, patient care, and scientific discovery continues to inspire future generations. As Director of Geriatrics at Southwest Hospital, his work advances both clinical and translational medicine, improving lives worldwide. With numerous influential publications and a commitment to pioneering treatments, his contributions to cardiac regeneration and aging prevention are invaluable. His legacy in medicine and academia ensures a lasting impact, shaping the future of healthcare and research.

TOP NOTABLE PUBLICATIONS

  • Title: Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?
    Authors: Xiaokang Chen, Hao Wu, Ya Liu, Lingyan Liu, Steven R. Houser, Wei Eric Wang
    Journal: Circulation
    Year: 2024

  • Title: Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ–NONO heteromer-induced DNA repair
    Authors: Wenbin Fu, Hongmei Ren, Jialing Shou, Qiao Liao, Liangpeng Li, Yu Shi, Pedro A. Jose, Chunyu Zeng, Wei Eric Wang
    Journal: Basic Research in Cardiology
    Year: 2022

  • Title: The Protective Role of Yin‐Yang 1 in Cardiac Injury and Remodeling After Myocardial Infarction
    Authors: Yu Huang, Liangpeng Li, Hongmei Chen, Qiao Liao, Xiaoli Yang, Dezhong Yang, Xuewei Xia, Hongyong Wang, Wei Eric Wang, Lianglong Chen et al.
    Journal: Journal of the American Heart Association
    Year: 2021

  • Title: The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction
    Authors: Wei Eric Wang, Liangpeng Li, Fu W, Gong X, Chen Z, Tang L, Yang D, Liao Q, Xia X, Wu H et al.
    Journal: European Heart Journal
    Year: 2021

  • Title: An Aurora Kinase B-Based Mouse System to Efficiently Identify and Analyze Proliferating Cardiomyocytes
    Authors: Wei Eric Wang, Fu W, Liao Q, Li L, Shi Y, Zeng A, Zeng C, Wang WE
    Journal: Frontiers in Cell and Developmental Biology
    Year: 2020

  • Title: Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart
    Authors: Wei Eric Wang, Zhang Y, Wang WE, Zhang X, Li Y, Chen B, Liu C, Ai X, Zhang X, Tian Y et al.
    Journal: Circulation Research
    Year: 2019

  • Title: Noncoding RNA and Cardiomyocyte Proliferation
    Authors: Shuang Qu, Chunyu Zeng, Wei Eric Wang
    Journal: Stem Cells International
    Year: 2017

  • Title: Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury
    Authors: Wei Eric Wang, Wang WE, Li L, Xia X, Fu W, Liao Q, Lan C, Yang D, Chen H, Yue R et al.
    Journal: Circulation
    Year: 2017

  • Title: Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium
    Authors: Wei Eric Wang, Wang WE, Yang D, Li L, Wang W, Peng Y, Chen C, Chen P, Xia X, Wang H et al.
    Journal: Circulation Research
    Year: 2013